The global oncology information systems market is expected to reach a value of US$ 5,828 million by 2033, indicating that it is ready for rapid growth. According to Future Market Insights, this is a significant increase from US$ 2,753.8 million in 2023, indicating a Compound Annual Growth Rate (CAGR) of 7.8%.
OIS solutions are essential to the delivery of contemporary oncology care because they simplify the management of patient data, enable more informed treatment choices, and eventually enhance patient outcomes.
Lead With Intelligence: Report Sample Awaits:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15150
Several key factors are propelling market growth:
- Healthcare IT Boom: The widespread adoption of healthcare IT solutions is creating a strong foundation for OIS integration within healthcare facilities.
- Global Cancer Burden: The rising prevalence of cancer worldwide is driving the demand for advanced tools to manage patient information and optimize treatment plans.
- Increased Investment in Cancer Research: Growing investments in cancer research and treatment development necessitate efficient data management systems, fueling the OIS market.
- Enhanced Workflow and Patient Care: OIS solutions streamline workflows for healthcare professionals, allowing them to dedicate more time to patient care and deliver more comprehensive treatment plans.
- Technological Advancements: Market players are continuously developing innovative OIS solutions with features like improved data capture, integration capabilities, and advanced analytics.
KEY TAKEAWAYS:
- The oncology information system market has been divided into two segments: solutions and professional services. The solutions segment accounted for the majority of revenue i.e. 73.4%.
- The solutions segment is further subdivided into patient information systems and treatment planning systems, with the latter accounting for the lion’s oncology information system market share.
- Medical oncology accounted for the largest oncology information system market share of global revenue, accounting for 61.4% of total revenue.
- information system market share’s revenue of 38.5%.
- The software segment accounted for 83.6% of the product and service oncology information system market.
- Radiation oncology accounted for 53.8% of the oncology information system market.
- Asia Pacific accounted for 17.8% of the oncology information system market.
Key Players Profiled in the Global Market:
- Elekta AB
- Accuray Inc.
- Varian Medical Systems
- RaySearch Laboratories
- Cerner Corp.
- BrainLab
- Philips Healthcare
- Prowess, Inc.
- DOSIsoft S.A.
- ViewRay Inc.
- MIM Software
- Flatiron
Since most of these well-known companies have extensive global distribution networks to reach their sizable customer bases, their influence on the oncology information systems market is quite significant.
The leading players in the oncology information systems market are concentrating on strategic initiatives like product launches, acquisitions, collaborations, participation in events, and expansions to boost revenue oncology information systems market growth and solidify their positions in the oncology information systems market,
Recent Developments
- Siemens Healthineers (Germany) completed its acquisition of the Varian Medical System in August 2021. (United Kingdom). This acquisition aimed to create a one-of-a-kind, highly integrated portfolio of oncology information system workflow. This acquisition might supplement the company’s existing oncology information system portfolio.
- In June 2021, Koninklijke Philips N.V. (The Netherlands) announced a collaboration with Elekta (Sweden) to develop advanced, comprehensive, and personalized cancer care through precision oncology information solutions.
- McKesson Corporation (USA) launched Ontada, an oncology technology and insights business dedicated to advancing cancer research and care, in December 2020.
- Elekta and Philips signed an agreement in June 2021 to strengthen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions.
- In January 2023, Philips Healthcare mentioned that it has increased, socially conscious healthcare leaders to recognize their responsibility for improving healthcare equality, as well as the need of reducing the sector’s carbon footprint for the preservation of the planet’s health.
Our Methodology Overview:
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15150
Key Segmentation:
By Product:
- Solutions
- Patient Information Systems
- Treatment Planning Systems
- Professional Services
By Application:
- Medical Oncology
- Radiation Oncology
- Surgical Oncology
By Region:
- North America
- The United States
- Canada
- Europe
- The United Kingdom
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- The Middle East & Africa
- Saudi Arabia
- South Africa
- United Arab Emirates
In-Depth Market Overview: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/15150
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
